Tefron Statistics

Total Valuation

Tefron has a market cap or net worth of ILS 354.36 million. The enterprise value is 378.37 million.

Market Cap	354.36M
Enterprise Value	378.37M

Important Dates

The next estimated earnings date is Thursday, November 21, 2024.

Earnings Date	Nov 21, 2024
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+3.53%
Shares Change (QoQ)	+4.88%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	3.89M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 3.18, with an EV/FCF ratio of 2.82.

EV / Earnings	6.74
EV / Sales	0.36
EV / EBITDA	3.18
EV / EBIT	4.11
EV / FCF	2.82

Financial Position

The company has a current ratio of 1.58, with a Debt / Equity ratio of 0.22.

Current Ratio	1.58
Quick Ratio	0.90
Debt / Equity	0.22
Debt / EBITDA	0.48
Debt / FCF	0.43
Interest Coverage	10.66

Financial Efficiency

Return on equity (ROE) is 23.44% and return on invested capital (ROIC) is 16.76%.

Return on Equity (ROE)	23.44%
Return on Assets (ROA)	10.19%
Return on Capital (ROIC)	16.76%
Revenue Per Employee	881,199
Profits Per Employee	47,410
Employee Count	1,184
Asset Turnover	1.86
Inventory Turnover	4.06

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +56.84% in the last 52 weeks. The beta is 1.10, so Tefron's price volatility has been similar to the market average.

Beta (5Y)	1.10
52-Week Price Change	+56.84%
50-Day Moving Average	2,954.12
200-Day Moving Average	2,583.17
Relative Strength Index (RSI)	63.14
Average Volume (20 Days)	15,967

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	136.08

Income Statement

In the last 12 months, Tefron had revenue of ILS 1.04 billion and earned 56.13 million in profits. Earnings per share was 4.26.

Revenue	1.04B
Gross Profit	237.87M
Operating Income	91.46M
Pretax Income	73.39M
Net Income	56.13M
EBITDA	118.39M
EBIT	91.46M
Earnings Per Share (EPS)	4.26

Full Income Statement

Balance Sheet

The company has 33.31 million in cash and 57.18 million in debt, giving a net cash position of -23.87 million.

Cash & Cash Equivalents	33.31M
Total Debt	57.18M
Net Cash	-23.87M
Net Cash Per Share	n/a
Equity (Book Value)	264.46M
Book Value Per Share	20.50
Working Capital	159.98M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 156.19 million and capital expenditures -22.02 million, giving a free cash flow of 134.17 million.

Operating Cash Flow	156.19M
Capital Expenditures	-22.02M
Free Cash Flow	134.17M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 22.80%, with operating and profit margins of 8.77% and 5.38%.

Gross Margin	22.80%
Operating Margin	8.77%
Pretax Margin	7.03%
Profit Margin	5.38%
EBITDA Margin	11.35%
EBIT Margin	8.77%
FCF Margin	12.86%

Dividends & Yields

Tefron does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	13.38%
Buyback Yield	-3.53%
Shareholder Yield	-3.53%
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Stock Splits

The last stock split was on January 22, 2009. It was a reverse split with a ratio of 0.1.

Last Split Date	Jan 22, 2009
Split Type	Reverse
Split Ratio	0.1

Scores

Tefron has an Altman Z-Score of 2.55. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.55
Piotroski F-Score	n/a